Overview
Axonis Therapeutics is a biotechnology company developing gene therapy treatments for spinal cord injury and neurological disorders using AAV vectors and shRNA technology to promote axon regeneration and neuroprotection. The company leverages advanced drug discovery platforms focused on regenerative medicine to address currently untreatable central nervous system injuries.
More in Neurotechnology
Latest industry news
China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race
2026-07-16 · Industry
NIH Confirms Brain-Computer Device Restores Speech in Human Patient
2026-07-15 · Research
Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans
2026-07-14 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-13 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →